{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:46:15Z","timestamp":1795020375305,"version":"4.10.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The inodilator levosimendan, in clinical use for over two decades, has been the subject of extensive clinical and experimental evaluation in various clinical settings beyond its principal indication in the management of acutely decompensated chronic heart failure. Critical care and emergency medicine applications for levosimendan have included postoperative settings, septic shock, and cardiogenic shock. As the experience in these areas continues to expand, an international task force of experts from 15 countries (Austria, Belgium, China, Croatia, Finland, France, Germany, Greece, Hungary, Italy, the Netherlands, Spain, Sweden, Switzerland, and the USA) reviewed and appraised the latest additions to the database of levosimendan use in critical care, considering all the clinical studies, meta-analyses, and guidelines published from September 2019 to November 2021. Overall, the authors of this opinion paper give levosimendan a \u201cshould be considered\u201d recommendation in critical care and emergency medicine settings, with different levels of evidence in postoperative settings, septic shock, weaning from mechanical ventilation, weaning from veno-arterial extracorporeal membrane oxygenation, cardiogenic shock, and Takotsubo syndrome, in all cases when an inodilator is needed to restore acute severely reduced left or right ventricular ejection fraction and overall haemodynamic balance, and also in the presence of renal dysfunction\/failure.<\/jats:p>","DOI":"10.1186\/s44158-021-00030-7","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T11:03:05Z","timestamp":1643022185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety"],"prefix":"10.1186","volume":"2","author":[{"given":"M.","family":"Girardis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bettex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Demponeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fruhwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"G\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. V.","family":"Groesdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guarracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Guerrero-Orriach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Heringlake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Herpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Heunks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kindgen-Milles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mauriat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Psallida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-E","family":"Ricksten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rudiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Siegemund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Toller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Treskatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017d.","family":"\u017dupan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6994-768X","authenticated-orcid":false,"given":"P.","family":"Pollesello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"30_CR1","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2020.03","volume":"6","author":"Z Papp","year":"2020","unstructured":"Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, \u010cern\u00fd V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, \u00c9des I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LM, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, P\u00f5der P, P\u00f6lzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RH, Toller W, Tritapepe L, Tsch\u00f6pe C, Wikstr\u00f6m G, von Lewinski D, Vrtovec B, Pollesello P (2020) Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. Card Fail Rev 6:e19. https:\/\/doi.org\/10.15420\/cfr.2020.03","journal-title":"Card Fail Rev"},{"issue":"1","key":"30_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/FJC.0000000000000636","volume":"73","author":"A Herpain","year":"2019","unstructured":"Herpain A, Bouchez S, Girardis M, Guarracino F, Knotzer J, Levy B, Liebregts T, Pollesello P, Ricksten S-E, Riha H, Rudiger A, Sangalli F (2019) Use of levosimendan in intensive care unit settings: an opinion paper. J Cardiovasc Pharmacol 73(1):3\u201314. https:\/\/doi.org\/10.1097\/FJC.0000000000000636","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"30_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/14779072.2021.19055204","volume":"19","author":"M Heringlake","year":"2021","unstructured":"Heringlake M, Alvarez J, Bettex D, Bouchez S, Fruhwald S, Girardis M, Grossini E, Guarracino F, Herpain A, Toller W, Tritapepe L, Pollesello P (2021) An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety. Expert Rev Cardiovasc Ther 19(4):325\u2013335. https:\/\/doi.org\/10.1080\/14779072.2021.19055204","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"30_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10557-013-6485-6","volume":"27","author":"MB Yilmaz","year":"2013","unstructured":"Yilmaz MB, Grossini E, Silva Cardoso JC, \u00c9des I, Fedele F, Pollesello P, Kivikko M, Harjola VP, Hasslacher J, Mebazaa A, Morelli A, le Noble J, Oldner A, Oulego Erroz I, Parissis JT, Parkhomenko A, Poelzl G, Rehberg S, Ricksten SE, Rodr\u00edguez Fern\u00e1ndez LM, Salmenper\u00e4 M, Singer M, Treskatsch S, Vrtovec B, Wikstr\u00f6m G (2013) Renal effects of levosimendan: a consensus report. Cardiovasc Drugs Ther 27(6):581\u2013590. https:\/\/doi.org\/10.1007\/s10557-013-6485-6","journal-title":"Cardiovasc Drugs Ther"},{"key":"30_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/97314676","volume":"2019","author":"J Pan","year":"2019","unstructured":"Pan J, Yang Y-M, Zhu J-Y, Lu Y-Q (2019) Multiorgan drug action of levosimendan in critical illnesses. BioMed Res Int 2019:1\u20138. https:\/\/doi.org\/10.1155\/2019\/97314676","journal-title":"BioMed Res Int"},{"issue":"05","key":"30_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1055\/s-0039-3400496","volume":"68","author":"C Weber","year":"2020","unstructured":"Weber C, Esser M, Eghbalzadeh K, Sabashnikov A, Djordjevic I, Maier J, Merkle J, Choi Y-H, Madershahian N, Liakopoulos O, Deppe AC, Wahlers TCW (2020) Levosimendan reduces mortality and low cardiac output syndrome in cardiac surgery. Thorac Cardiovasc Surg 68(05):401\u2013409. https:\/\/doi.org\/10.1055\/s-0039-3400496","journal-title":"Thorac Cardiovasc Surg"},{"issue":"1","key":"30_CR7","doi-asserted-by":"publisher","first-page":"20343","DOI":"10.1038\/s41598-019-56831-y","volume":"9","author":"S Terbeck","year":"2019","unstructured":"Terbeck S, Heinisch PP, Lenz A, Friess JO, Guensch D, Carrel T, Eberle B, Erdoes G (2019) Levosimendan and systemic vascular resistance in cardiac surgery patients: a systematic review and meta-analysis. Sci Rep 9(1):20343. https:\/\/doi.org\/10.1038\/s41598-019-56831-y","journal-title":"Sci Rep"},{"issue":"7","key":"30_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1177\/0267659120963909","volume":"36","author":"Y-T Yao","year":"2021","unstructured":"Yao Y-T, He L-X, Zhao Y-Y (2021) The effect of levosimendan on postoperative bleeding and blood transfusion in cardiac surgical patients: a PRISMA-compliant systematic review and meta-analysis. Perfusion 36(7):694\u2013703. https:\/\/doi.org\/10.1177\/0267659120963909","journal-title":"Perfusion"},{"issue":"2","key":"30_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40256-019-00372-2","volume":"20","author":"S Yan","year":"2020","unstructured":"Yan S, Wang X, Shang G, Wang Z, Deng Q, Song J, Sai W, Song M, Zhong M, Zhang W (2020) Impact of perioperative levosimendan administration on risk of bleeding after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Cardiovasc Drugs 20(2):149\u2013160. https:\/\/doi.org\/10.1007\/s40256-019-00372-2","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"30_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.6002\/ect.2020.0342","volume":"19","author":"MB Immohr","year":"2021","unstructured":"Immohr MB, Akhyari P, Boettger C, Erbel S, Westenfeld R, Scheiber D, Tudorache I, Aubin H, Lichtenberg A, Boeken U (2021) Levosimendan for treatment of primary graft dysfunction after heart transplantation: optimal timing of application. Exp Clin Transplant 19(5):473\u2013480. https:\/\/doi.org\/10.6002\/ect.2020.0342","journal-title":"Exp Clin Transplant"},{"issue":"6","key":"30_CR11","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.jtcvs.2019.06.020o","volume":"159","author":"S van Diepen","year":"2020","unstructured":"van Diepen S, Mehta RH, Leimberger JD, Goodman SG, Fremes S, Jankowich R, Heringlake M, Anstrom KJ, Levy JH, Luber J, Nagpal AD, Duncan AE, Argenziano M, Toller W, Teoh K, Knight JD, Lopes RD, Cowper PA, Mark DB, Alexander JH (2020) Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. J Thorac Cardiovasc Surg 159(6):2302\u20132309.e6. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.06.020o","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"30_CR12","doi-asserted-by":"publisher","first-page":"E093","DOI":"10.1532\/hsf.2731","volume":"23","author":"A Omar","year":"2020","unstructured":"Omar A, Eldegwy M, Allam M, Rouchdy A, Soliman SAH, Dawou O, Elshihy E (2020) Comparison of levosimendan versus IABP in patients with poor left ventricular function undergoing coronary artery bypass graft surgery. Heart Surg Forum 23(1):E093\u2013E097. https:\/\/doi.org\/10.1532\/hsf.2731","journal-title":"Heart Surg Forum"},{"issue":"19","key":"30_CR13","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.3889\/oamjms.2019.675","volume":"7","author":"M Khaled","year":"2019","unstructured":"Khaled M, Almogy AN, Shehata M, Ragab F, Zeineldein K (2019) Effect of Levosimendan compared to conventional inotropic agents on hemodynamics and outcome in patient with poor LV function undergoing cardiac surgery. Open Access Maced J Med Sci 7(19):3205\u20133210. https:\/\/doi.org\/10.3889\/oamjms.2019.675","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"30_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13019-020-01140-z","volume":"15","author":"JJ Jim\u00e9nez-Rivera","year":"2020","unstructured":"Jim\u00e9nez-Rivera JJ, \u00c1lvarez-Castillo A, Ferrer-Rodr\u00edguez J, Iribarren-Sarr\u00edas JL, Garc\u00eda-Gonz\u00e1lez MJ, Jorge-P\u00e9rez P, Lacalzada-Almeida J, P\u00e9rez-Hern\u00e1ndez R, Montoto-L\u00f3pez J, Mart\u00ednez-Sanz R (2020) Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy. J Cardiothorac Surg 15(1):108. https:\/\/doi.org\/10.1186\/s13019-020-01140-z","journal-title":"J Cardiothorac Surg"},{"key":"30_CR15","doi-asserted-by":"publisher","unstructured":"Stefanelli G, Bellisario A, Meli M, Chiurlia E, Barbieri A, Weltert L (2020) Outcomes after surgical ventricular restoration for ischemic cardiomyopathy. J Thorac Cardiovasc Surg S0022522320312368. https:\/\/doi.org\/10.1016\/j.jtcvs.2020.04.167","DOI":"10.1016\/j.jtcvs.2020.04.167"},{"key":"30_CR16","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.932001","volume":"27","author":"W Sheng","year":"2021","unstructured":"Sheng W, Qiao H, Niu Z, Wang T, Li H, Zhang W, Wu J, Lv X (2021) Prospective study on the postoperative use of levosimendan after conventional heart valve replacement. Med Sci Monit 27:e932001. https:\/\/doi.org\/10.12659\/MSM.932001","journal-title":"Med Sci Monit"},{"issue":"1","key":"30_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13613-020-00709-0","volume":"10","author":"P Mauriat","year":"2020","unstructured":"Mauriat P, Bojan M, Soulie S, Foulgoc H, Tafer N, Ouattara A (2020) Impact of the perioperative inotropic support in grown-up congenital heart patients undergoing cardiac surgery: a propensity score adjusted analysis. Ann Intens Care 10(1):91. https:\/\/doi.org\/10.1186\/s13613-020-00709-0","journal-title":"Ann Intens Care"},{"key":"30_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijcard.2015.02.022","volume":"184","author":"W Toller","year":"2015","unstructured":"Toller W, Heringlake M, Guarracino F, Algotsson L, Alvarez J, Argyriadou H, Ben-Gal T, \u010cern\u00fd V, Cholley B, Eremenko A, Guerrero-Orriach JL, J\u00e4rvel\u00e4 K, Karanovic N, Kivikko M, Lahtinen P, Lomivorotov V, Mehta RH, Mu\u0161i\u010d \u0160, Pollesello P, Rex S, Riha H, Rudiger A, Salmenper\u00e4 M, Szudi L, Tritapepe L, Wyncoll D, \u00d6wall A (2015) Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion. Int J Cardiol 184:323\u2013336. https:\/\/doi.org\/10.1016\/j.ijcard.2015.02.022","journal-title":"Int J Cardiol"},{"issue":"1","key":"30_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FJC.0000000000000551","volume":"71","author":"F Guarracino","year":"2018","unstructured":"Guarracino F, Heringlake M, Cholley B, Bettex D, Bouchez S, Lomivorotov VV, Rajek A, Kivikko M, Pollesello P (2018) Use of levosimendan in cardiac surgery: an update after the LEVO-CTS, CHEETAH, and LICORN trials in the light of clinical practice. J Cardiovasc Pharmacol 71(1):1\u20139. https:\/\/doi.org\/10.1097\/FJC.0000000000000551","journal-title":"J Cardiovasc Pharmacol"},{"key":"30_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijcard.2017.10.077","volume":"251","author":"A Putzu","year":"2018","unstructured":"Putzu A, Clivio S, Belletti A, Cassina T (2018) Perioperative levosimendan in cardiac surgery: a systematic review with meta-analysis and trial sequential analysis. Int J Cardiol 251:22\u201331. https:\/\/doi.org\/10.1016\/j.ijcard.2017.10.077","journal-title":"Int J Cardiol"},{"key":"30_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijcard.2021.02.050","volume":"333","author":"MJ Jaguszewski","year":"2021","unstructured":"Jaguszewski MJ, Gasecka A, Filipiak KJ, Szarpak L (2021) Levosimendan or dobutamine in patients with low cardiac output syndrome: results from meta-analysis. Int J Cardiol 333:145. https:\/\/doi.org\/10.1016\/j.ijcard.2021.02.050","journal-title":"Int J Cardiol"},{"issue":"3","key":"30_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00101-020-00860-0","volume":"70","author":"T Woehrle","year":"2021","unstructured":"Woehrle T, Mehringer L, Juchem G, Dashkevich A, Weis M, Sch\u00fcnemann M, Kilger E (2021) Individualized use of levosimendan in cardiac surgery [German]. Anaesthesist 70(3):204\u2013212. https:\/\/doi.org\/10.1007\/s00101-020-00860-0","journal-title":"Anaesthesist"},{"issue":"21","key":"30_CR23","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa1616325","volume":"376","author":"G Landoni","year":"2017","unstructured":"Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabr\u00f2 MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A, Pasyuga VV, Baiocchi M, Pappalardo F, Monaco F, Boboshko VA, Abubakirov MN, Amantea B, Lembo R, Brazzi L, Verniero L, Bertini P, Scandroglio AM, Bove T, Belletti A, Michienzi MG, Shukevich DL, Zabelina TS, Bellomo R, Zangrillo A (2017) Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med 376(21):2021\u20132031. https:\/\/doi.org\/10.1056\/NEJMoa1616325","journal-title":"N Engl J Med"},{"issue":"6","key":"30_CR24","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2017.9973","volume":"318","author":"B Cholley","year":"2017","unstructured":"Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, L\u00e9vy F, Squara P, A\u00eft Hamou N, Carillon A, Boyer J, Boughenou M-F, Rosier S, Robin E, Radutoiu M, Durand M, Guidon C, Desebbe O, Charles-Nelson A, Menasch\u00e9 P, Rozec B, Girard C, Fellahi J-L, Pirracchio R, Chatellier G (2017) Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial. JAMA 318(6):548\u2013556. https:\/\/doi.org\/10.1001\/jama.2017.9973","journal-title":"JAMA"},{"issue":"1","key":"30_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/ejcts\/ezz159","volume":"57","author":"SS Kocabeyoglu","year":"2020","unstructured":"Kocabeyoglu SS, Kervan U, Sert DE, Karahan M, Aygun E, Beyazal OF, Unal EU, Akin Y, Demirkan B, Pac M (2020) Optimization with levosimendan improves outcomes after left ventricular assist device implantation. Eur J Cardio-Thoracic Surg 57(1):176\u2013182. https:\/\/doi.org\/10.1093\/ejcts\/ezz159","journal-title":"Eur J Cardio-Thoracic Surg"},{"issue":"1","key":"30_CR26","doi-asserted-by":"publisher","first-page":"20333","DOI":"10.1038\/s41598-021-99716-9","volume":"11","author":"D-H Liu","year":"2021","unstructured":"Liu D-H, Ning Y-L, Lei Y-Y, Chen J, Liu Y-Y, Lin X-F, Yang Z-Q, Xian S-X, Chen W-T (2021) Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis. Sci Rep 11(1):20333. https:\/\/doi.org\/10.1038\/s41598-021-99716-9","journal-title":"Sci Rep"},{"issue":"10","key":"30_CR27","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/CM9.0000000000000197","volume":"132","author":"F Feng","year":"2019","unstructured":"Feng F, Chen Y, Li M, Yuan J-J, Chang X-N, Dong C-M (2019) Levosimendan does not reduce the mortality of critically ill adult patients with sepsis and septic shock: a meta-analysis. Chin Med J 132(10):1212\u20131217. https:\/\/doi.org\/10.1097\/CM9.0000000000000197","journal-title":"Chin Med J"},{"issue":"17","key":"30_CR28","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","volume":"375","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RML, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375(17):1638\u20131648. https:\/\/doi.org\/10.1056\/NEJMoa1609409","journal-title":"N Engl J Med"},{"issue":"10","key":"30_CR29","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1007\/s00134-019-05731-w","volume":"45","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe DB, Santhakumaran S, Orme RML, Ward JK, Al-Beidh F, O\u2019Dea K, Perkins GD, Singer M, McAuley DF, Mason AJ, Cross M, Ashby D, Gordon AC (2019) Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial. Intensive Care Med 45(10):1392\u20131400. https:\/\/doi.org\/10.1007\/s00134-019-05731-w","journal-title":"Intensive Care Med"},{"issue":"5","key":"30_CR30","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jcrc.2015.05.017","volume":"30","author":"A Zangrillo","year":"2015","unstructured":"Zangrillo A, Putzu A, Monaco F, Oriani A, Frau G, De Luca M, Di Tomasso N, Bignami E, Lomivorotov V, Likhvantsev V, Landoni G (2015) Levosimendan reduces mortality in patients with severe sepsis and septic shock: a meta-analysis of randomized trials. J Crit Care 30(5):908\u2013913. https:\/\/doi.org\/10.1016\/j.jcrc.2015.05.017","journal-title":"J Crit Care"},{"issue":"8","key":"30_CR31","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1056\/NEJMc1616632","volume":"376","author":"HH Groesdonk","year":"2017","unstructured":"Groesdonk HH, Sander M, Heringlake M (2017) Levosimendan in sepsis. N Engl J Med 376(8):798\u2013800. https:\/\/doi.org\/10.1056\/NEJMc1616632","journal-title":"N Engl J Med"},{"key":"30_CR32","doi-asserted-by":"publisher","first-page":"154916","DOI":"10.1016\/j.cyto.2019.154916","volume":"126","author":"J Li","year":"2020","unstructured":"Li J, Sun W, Guo Y, Ren Y, Li Y, Yang Z (2020) Prognosis of \u03b2-adrenergic blockade therapy on septic shock and sepsis: a systematic review and meta-analysis of randomized controlled studies. Cytokine 126:154916. https:\/\/doi.org\/10.1016\/j.cyto.2019.154916","journal-title":"Cytokine"},{"issue":"9","key":"30_CR33","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/CCM.0000000000005034","volume":"49","author":"K Tan","year":"2021","unstructured":"Tan K, Harazim M, Simpson A, Tan YC, Gunawan G, Robledo KP, Whitehead C, Tang B, Mclean A, Nalos M (2021) Association between premorbid beta-blocker exposure and sepsis outcomes\u2014the Beta-Blockers in European and Australian\/American Septic Patients (BEAST) Study. Crit Care Med 49(9):1493\u20131503. https:\/\/doi.org\/10.1097\/CCM.0000000000005034","journal-title":"Crit Care Med"},{"issue":"11","key":"30_CR34","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1097\/CCM.0000000000005357","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Joost Wiersinga W, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Yataco AC, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, M\u00f8ller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021. Crit Care Med 49(11):1974\u20131982. https:\/\/doi.org\/10.1097\/CCM.0000000000005357","journal-title":"Crit Care Med"},{"issue":"9","key":"30_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-037188","volume":"10","author":"I Cappellini","year":"2020","unstructured":"Cappellini I, Melai A, Zamidei L, Parise M, Cipani S, Consales G (2020) Levosimendan and Global Longitudinal Strain Assessment in Sepsis (GLASSES 1): a study protocol for an observational study. BMJ Open 10(9):e037188. https:\/\/doi.org\/10.1136\/bmjopen-2020-037188","journal-title":"BMJ Open"},{"issue":"8","key":"30_CR36","doi-asserted-by":"publisher","first-page":"e12729","DOI":"10.1111\/micc.12729","volume":"28","author":"F Vo\u00df","year":"2021","unstructured":"Vo\u00df F, Karbenn M, Hoffmann T, Schweitzer J, Jung C, Bernhard M, Kienbaum P, Kelm M, Westenfeld R (2021) Sublingual microcirculation predicts survival after out-of-hospital cardiac arrest. Microcirculation 28(8):e12729. https:\/\/doi.org\/10.1111\/micc.12729","journal-title":"Microcirculation"},{"issue":"1","key":"30_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13054-021-03813-0","volume":"25","author":"J-L Vincent","year":"2021","unstructured":"Vincent J-L, Singer M, Einav S, Moreno R, Wendon J, Teboul J-L, Bakker J, Hernandez G, Annane D, de Man AME, Monnet X, Ranieri VM, Hamzaoui O, Takala J, Juffermans N, Chiche J-D, Myatra SN, De Backer D (2021) Equilibrating SSC guidelines with individualized care. Crit Care 25(1):397. https:\/\/doi.org\/10.1186\/s13054-021-03813-0","journal-title":"Crit Care"},{"issue":"12","key":"30_CR38","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1097\/CCM.0000000000004000","volume":"47","author":"CA Santacruz","year":"2019","unstructured":"Santacruz CA, Pereira AJ, Celis E, Vincent J-L (2019) Which multicenter randomized controlled trials in critical care medicine have shown reduced mortality? A systematic review: Crit Care Med 47(12):1680\u20131691. https:\/\/doi.org\/10.1097\/CCM.0000000000004000","journal-title":"A systematic review: Crit Care Med"},{"issue":"9","key":"30_CR39","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/17512433.2019.1643235","volume":"12","author":"J-L Vincent","year":"2019","unstructured":"Vincent J-L, Sakr Y (2019) Clinical trial design for unmet clinical needs: a spotlight on sepsis. Expert Rev Clin Pharmacol 12(9):893\u2013900. https:\/\/doi.org\/10.1080\/17512433.2019.1643235","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"30_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/CCM.0000000000002851","volume":"46","author":"SJ Beesley","year":"2018","unstructured":"Beesley SJ, Weber G, Sarge T, Nikravan S, Grissom CK, Lanspa MJ, Shahul S, Brown SM (2018) Septic cardiomyopathy. Crit Care Med 46(4):625\u2013634. https:\/\/doi.org\/10.1097\/CCM.0000000000002851","journal-title":"Crit Care Med"},{"key":"30_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7169492","volume":"2019","author":"I Kaltsi","year":"2019","unstructured":"Kaltsi I, Angelopoulos E, Tzanis G, Sideris A, Tyrovolas K, Kokkoris S, Gratziou C, Nanas S, Routsi C (2019) Contribution of levosimendan in weaning from mechanical ventilation in patients with left ventricular dysfunction: a pilot study. Crit Care Res Pract 2019:1\u20138. https:\/\/doi.org\/10.1155\/2019\/7169492","journal-title":"Crit Care Res Pract"},{"issue":"1","key":"30_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1164\/rccm.201107-1268OC","volume":"185","author":"J Doorduin","year":"2012","unstructured":"Doorduin J, Sinderby CA, Beck J, Stegeman DF, van Hees HWH, van der Hoeven JG, Heunks LMA (2012) The calcium sensitizer levosimendan improves human diaphragm function. Am J Respir Crit Care Med 185(1):90\u201395. https:\/\/doi.org\/10.1164\/rccm.201107-1268OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"30_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1164\/rccm.200805-732OC","volume":"179","author":"HWH van Hees","year":"2009","unstructured":"van Hees HWH, Dekhuijzen PNR, Heunks LMA (2009) Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 179(1):41\u201347. https:\/\/doi.org\/10.1164\/rccm.200805-732OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"30_CR44","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/ALN.0000000000000224","volume":"120","author":"DV Nielsen","year":"2014","unstructured":"Nielsen DV, Hansen MK, Johnsen SP, Hansen M, Hindsholm K, Jakobsen C-J (2014) Health outcomes with and without use of inotropic therapy in cardiac surgery. Anesthesiology 120(5):1098\u20131108. https:\/\/doi.org\/10.1097\/ALN.0000000000000224","journal-title":"Anesthesiology"},{"issue":"6","key":"30_CR45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1177\/0267659120918473","volume":"35","author":"LM Burgos","year":"2020","unstructured":"Burgos LM, Seoane L, Furmento JF, Costabel JP, Diez M, Vrancic M, Aissaoui N, Benzad\u00f3n MN, Navia D (2020) Effects of levosimendan on weaning and survival in adult cardiogenic shock patients with veno-arterial extracorporeal membrane oxygenation: systematic review and meta-analysis. Perfusion 35(6):484\u2013491. https:\/\/doi.org\/10.1177\/0267659120918473","journal-title":"Perfusion"},{"issue":"8","key":"30_CR46","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1053\/j.jvca.2021.01.019","volume":"35","author":"R Kaddoura","year":"2021","unstructured":"Kaddoura R, Omar AS, Ibrahim MIM, Alkhulaifi A, Lorusso R, Elsherbini H, Soliman O, Caliskan K (2021) The effectiveness of levosimendan on veno-arterial extracorporeal membrane oxygenation management and outcome: a systematic review and meta-analysis. J Cardiothoracic Vasc Anesth 35(8):2483\u20132495. https:\/\/doi.org\/10.1053\/j.jvca.2021.01.019","journal-title":"J Cardiothoracic Vasc Anesth"},{"key":"30_CR47","doi-asserted-by":"publisher","unstructured":"Yang B, Zhao T, Guo B, Li Y (2021) Short-term effects of levosimendan use for venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Perfusion.:026765912110518. https:\/\/doi.org\/10.1177\/02676591211051860","DOI":"10.1177\/02676591211051860"},{"key":"30_CR48","doi-asserted-by":"publisher","first-page":"741108","DOI":"10.3389\/fmed.2021.741108","volume":"8","author":"J-C Luo","year":"2021","unstructured":"Luo J-C, Zheng W-H, Meng C, Zhou H, Xu Y, Tu G-W, Luo Z, Huang H-B (2021) Levosimendan to facilitate weaning from cardiorespiratory support in critically Ill patients: a meta-analysis. Front Med 8:741108. https:\/\/doi.org\/10.3389\/fmed.2021.741108","journal-title":"Front Med"},{"issue":"1","key":"30_CR49","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13054-020-03122-y","volume":"24","author":"E Guilherme","year":"2020","unstructured":"Guilherme E, Jacquet-Lagr\u00e8ze M, Pozzi M, Achana F, Armoiry X, Fellahi J-L (2020) Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis. Crit Care 24(1):442. https:\/\/doi.org\/10.1186\/s13054-020-03122-y","journal-title":"Crit Care"},{"issue":"7","key":"30_CR50","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/aor.13899","volume":"45","author":"M Alonso-Fernandez-Gatta","year":"2021","unstructured":"Alonso-Fernandez-Gatta M, Merchan-Gomez S, Gonzalez-Cebrian M, Diego-Nieto A, Alzola E, Toranzo-Nieto I, Barrio A, Martin-Herrero F, Sanchez PL (2021) Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: impact on the success of weaning and survival. Artif Organs 45(7):717\u2013725. https:\/\/doi.org\/10.1111\/aor.13899","journal-title":"Artif Organs"},{"key":"30_CR51","doi-asserted-by":"publisher","unstructured":"Mahesh B, Williams L, Punjabi PP, Katsaridis S (2021) Novel strategy for improved outcomes of extra-corporeal membrane oxygenation as a treatment for refractory post cardiotomy cardiogenic shock in the current era: a refreshing new perspective. Perfusion.:026765912110233. https:\/\/doi.org\/10.1177\/02676591211023304","DOI":"10.1177\/02676591211023304"},{"issue":"1","key":"30_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13019-017-0618-0","volume":"12","author":"M Khorsandi","year":"2017","unstructured":"Khorsandi M, Dougherty S, Bouamra O, Pai V, Curry P, Tsui S, Clark S, Westaby S, Al-Attar N, Zamvar V (2017) Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Surg 12(1):55. https:\/\/doi.org\/10.1186\/s13019-017-0618-0","journal-title":"J Cardiothorac Surg"},{"issue":"4","key":"30_CR53","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1053\/j.jvca.2014.12.011","volume":"29","author":"F Pappalardo","year":"2015","unstructured":"Pappalardo F, Pieri M, Arnaez Corada B, Ajello S, Melisurgo G, De Bonis M, Zangrillo A (2015) Timing and strategy for weaning from venoarterial ECMO are complex issues. J Cardiothoracic Vasc Anesth 29(4):906\u2013911. https:\/\/doi.org\/10.1053\/j.jvca.2014.12.011","journal-title":"J Cardiothoracic Vasc Anesth"},{"issue":"4","key":"30_CR54","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1002\/ehf2.13427","volume":"8","author":"O Ellouze","year":"2021","unstructured":"Ellouze O, Soudry Faure A, Radhouani M, Abou-Arab O, Besnier E, Moussa M, Cransac A, Ksiazek E, Fischer M, Mertes PM, Bouhemad B, Guinot PG (2021) Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial. ESC Heart Fail 8(4):3339\u20133347. https:\/\/doi.org\/10.1002\/ehf2.13427","journal-title":"ESC Heart Fail"},{"issue":"6","key":"30_CR55","doi-asserted-by":"publisher","first-page":"645","DOI":"10.23736\/S0375-9393.20.14219-6","volume":"86","author":"F Sangalli","year":"2020","unstructured":"Sangalli F, Bellani G, Affronti A, Volpi F, Feri M, Marini M, Quacquarelli A, Vitale D, Guarracino F (2020) Levosimendan to facilitate weaning from cardiorespiratory support in critically ill patients: current evidence and future directions. Minerva Anestesiol 86(6):645\u2013651. https:\/\/doi.org\/10.23736\/S0375-9393.20.14219-6","journal-title":"Minerva Anestesiol"},{"issue":"36","key":"30_CR56","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, ESC Scientific Document Group, de Boer RA, Christian Schulze P, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-Genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, L\u00f8chen M-L, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen J-C, Neubeck L, Noutsias M, Petersen SE, Sonia Petronio A, Ponikowski P, Prescott E, Rakisheva A, Richter DJ, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-Uva M, Tocchetti CG, Touyz RM, Tschoepe C, Waltenberger J, Adamo M, Baumbach A, B\u00f6hm M, Burri H, \u010celutkien\u0117 J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"11","key":"30_CR57","doi-asserted-by":"publisher","first-page":"CD009669","DOI":"10.1002\/14651858.CD009669.pub4","volume":"11","author":"K Uhlig","year":"2020","unstructured":"Uhlig K, Efremov L, Tongers J, Frantz S, Mikolajczyk R, Sedding D, Schumann J (2020) Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev 11(11):CD009669. https:\/\/doi.org\/10.1002\/14651858.CD009669.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"30_CR58","doi-asserted-by":"publisher","unstructured":"Liao X, Qian L, Zhang S, Chen X, Lei J (2020) Network meta-analysis of the safety of drug therapy for cardiogenic shock. J Healthc Eng:8862256. https:\/\/doi.org\/10.1155\/2020\/8862256","DOI":"10.1155\/2020\/8862256"},{"issue":"10","key":"30_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/jcdd8100129","volume":"8","author":"G Tumminello","year":"2021","unstructured":"Tumminello G, Cereda A, Barbieri L, Biondi-Zoccai G, Lucreziotti S, Mafrici A, Carugo S (2021) Meta-analysis of placebo-controlled trials of levosimendan in acute myocardial infarction. J Cardiovasc Dev Dis 8(10):129. https:\/\/doi.org\/10.3390\/jcdd8100129","journal-title":"J Cardiovasc Dev Dis"},{"key":"30_CR60","doi-asserted-by":"publisher","unstructured":"Wang YH, Chen JL, Tsai CS, Tsai YT, Lin CY, Ke HY, Hsu PS (2021) Effects of levosimendan on systemic perfusion in patients with low Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) score: experience from a single center in Taiwan Acta Cardiol Sin 37(5):512\u2013521. https:\/\/doi.org\/10.6515\/ACS.202109_37(5).20210310B.","DOI":"10.6515\/ACS.202109_37"},{"issue":"2","key":"30_CR61","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/jcm9020373","volume":"9","author":"E Grossini","year":"2020","unstructured":"Grossini E, Farruggio S, Pierelli D, Bolzani V, Rossi L, Pollesello P, Monaco C (2020) Levosimendan improves oxidative balance in cardiogenic shock\/low cardiac output patients. J Clin Med 9(2):373. https:\/\/doi.org\/10.3390\/jcm9020373","journal-title":"J Clin Med"},{"key":"30_CR62","doi-asserted-by":"publisher","unstructured":"Fox H, Gummert JF, Sommer P, Knabbe C, Sohns C (2021) Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: a case report Cardiol J. https:\/\/doi.org\/10.5603\/CJ.a2021.0119","DOI":"10.5603\/CJ.a2021.0119"},{"issue":"2","key":"30_CR63","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsk\u00fd P, ESC Scientific Document Group, Collet J-P, Kristensen SD, Aboyans V, Baumbach A, Bugiardini R, Coman IM, Delgado V, Fitzsimons D, Gaemperli O, Gershlick AH, Gielen S, Harjola V-P, Katus HA, Knuuti J, Kolh P, Leclercq C, Lip GYH, Morais J, Neskovic AN, Neumann F-J, Niessner A, Piepoli MF, Richter DJ, Shlyakhto E, Simpson IA, Steg PG, Terkelsen CJ, Thygesen K, Windecker S, Zamorano JL, Zeymer U, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet J-P, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, J\u00fcni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, McDonagh T, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Simpson IA, Zamorano JL, Chettibi M, Hayrapetyan HG, Metzler B, Ibrahimov F, Sujayeva V, Beauloye C, Dizdarevic-Hudic L, Karamfiloff K, Skoric B, Antoniades L, Tousek P, Terkelsen PJ, Shaheen SM, Marandi T, Niemel\u00e4 M, Kedev S, Gilard M, Aladashvili A, Elsaesser A, Kanakakis IG, Merkely B, Gudnason T, Iakobishvili Z, Bolognese L, Berkinbayev S, Bajraktari G, Beishenkulov M, Zake I, Lamin HB, Gustiene O, Pereira B, Xuereb RG, Ztot S, Julieb\u00f8 V, Legutko J, Tim\u00f3teo AT, Tatu-Chi\u0163oiu G, Yakovlev A, Bertelli L, Nedeljkovic M, Studen\u010dan M, Bunc M, Garc\u00eda de Castro AM, Petursson P, Jeger R, Mourali MS, Yildirir A, Parkhomenko A, Gale CP (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 39(2):119\u2013177. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393","journal-title":"Eur Heart J"},{"issue":"6","key":"30_CR64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3238\/arztebl.m2021.0012","volume":"118","author":"Werdan K, Buerke M, Geppert A, Thiele H, Zwissler B, Ru\u00df M; guideline group","year":"2021","unstructured":"Werdan K, Buerke M, Geppert A, Thiele H, Zwissler B, Ru\u00df M; guideline group (2021) Infarction-related cardiogenic shock\u2014diagnosis, monitoring and therapy. Dtsch Arztebl Int 118(6):88\u201395. https:\/\/doi.org\/10.3238\/arztebl.m2021.0012","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"30_CR65","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/MCC.0000000000000822","volume":"27","author":"D De Backer","year":"2021","unstructured":"De Backer D, Arias Ortiz J, Levy B (2021) The medical treatment of cardiogenic shock: cardiovascular drugs. Curr Opin Crit Care 27(4):426\u2013432. https:\/\/doi.org\/10.1097\/MCC.0000000000000822","journal-title":"Curr Opin Crit Care"},{"issue":"6","key":"30_CR66","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11897-020-00493-9","volume":"17","author":"A Shabana","year":"2020","unstructured":"Shabana A, Dholoo F, Banerjee P (2020) Inotropic agents and vasopressors in the treatment of cardiogenic shock. Curr Heart Fail Rep 17(6):438\u2013448. https:\/\/doi.org\/10.1007\/s11897-020-00493-9","journal-title":"Curr Heart Fail Rep"},{"issue":"5","key":"30_CR67","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1002\/ehf2.13486","volume":"8","author":"MJ Jaguszewski","year":"2021","unstructured":"Jaguszewski MJ, Gasecka A, Hering D, Filipiak KJ, Szarpak L, Fija\u0142kowski M, Grucha\u0142a M (2021) Levosimendan improves the acute course of takotsubo syndrome: a pooled analysis. ESC Heart Fail 8(5):4360\u20134363. https:\/\/doi.org\/10.1002\/ehf2.13486","journal-title":"ESC Heart Fail"},{"issue":"21","key":"30_CR68","doi-asserted-by":"publisher","first-page":"e011194","DOI":"10.1161\/JAHA.118.011194","volume":"8","author":"S Jurisic","year":"2019","unstructured":"Jurisic S, Gili S, Cammann VL, Kato K, Szawan KA, D\u2019Ascenzo F, Jaguszewski M, Bossone E, Citro R, Sarcon A, Napp LC, Franke J, Noutsias M, Knorr M, Heiner S, Burgdorf C, Koenig W, Pott A, Kherad B, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Karakas M, Meyer P, Arroja JD, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Dworakowski R, Kaiser C, Osswald S, Galiuto L, Dichtl W, Chan C, Bridgman P, Beug D, Delmas C, Lairez O, Kozel M, Tousek P, Winchester DE, Gilyarova E, Shilova A, Gilyarov M, El-Battrawy I, Akin I, Galuszka J, Ukena C, Poglajen G, Paolini C, Bilato C, Carrilho-Ferreira P, Pinto FJ, Opolski G, MacCarthy P, Kobayashi Y, Prasad A, Rihal CS, Widimsk\u00fd P, Horowitz JD, Di Mario C, Crea F, Tsch\u00f6pe C, Pieske BM, Hasenfu\u00df G, Rottbauer W, Braun-Dullaeus RC, Felix SB, Borggrefe M, Thiele H, Bauersachs J, Katus HA, Schunkert H, M\u00fcnzel T, B\u00f6hm M, Bax JJ, L\u00fcscher TF, Ruschitzka F, Ghadri JR, Templin C (2019) Clinical predictors and prognostic impact of recovery of wall motion abnormalities in Takotsubo syndrome: results from the International Takotsubo Registry. J Am Heart Assoc 8(21):e011194. https:\/\/doi.org\/10.1161\/JAHA.118.011194","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"30_CR69","doi-asserted-by":"publisher","first-page":"438","DOI":"10.21037\/atm.2018.10.15","volume":"6","author":"Y Guo","year":"2018","unstructured":"Guo Y, Zhou C, Yang X (2018) Efficacy and safety of levosimendan in Chinese elderly patients with Takotsubo syndrome. Ann Transl Med 6(22):438\u2013438. https:\/\/doi.org\/10.21037\/atm.2018.10.15","journal-title":"Ann Transl Med"},{"issue":"5","key":"30_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.21037\/atm.2019.02.01","volume":"7","author":"J Finsterer","year":"2019","unstructured":"Finsterer J, St\u00f6llberger C (2019) Beneficiality of levosimendan for Takotsubo syndrome remains uncertain. Ann Transl Med 7(5):109\u2013109. https:\/\/doi.org\/10.21037\/atm.2019.02.01","journal-title":"Ann Transl Med"},{"issue":"11","key":"30_CR71","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jchf.2018.05.015","volume":"6","author":"M Almendro-Delia","year":"2018","unstructured":"Almendro-Delia M, N\u00fa\u00f1ez-Gil IJ, Lobo M, Andr\u00e9s M, Vedia O, Sionis A, Martin-Garc\u00eda A, Cruz Aguilera M, Pereyra E, Mart\u00edn de Miguel I, Linares Vicente JA, Corb\u00ed-Pascual M, Bosch X, Fabregat Andr\u00e9s O, S\u00e1nchez Grande Flecha A, P\u00e9rez-Castellanos A, Pais JL, De Mora MM, Escudier Villa JM, Mart\u00edn Asenjo R, Guillen Marzo M, Rueda Sobella F, Ace\u00f1a \u00c1, Garc\u00eda Acu\u00f1a JM, Garc\u00eda-Rubira JC, Investigators RETAKO (2018) Short- and long-term prognostic relevance of cardiogenic shock in Takotsubo syndrome: results from the RETAKO Registry. JACC Heart Fail 6(11):928\u2013936. https:\/\/doi.org\/10.1016\/j.jchf.2018.05.015","journal-title":"JACC Heart Fail"},{"issue":"1","key":"30_CR72","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13054-021-03824-x","volume":"25","author":"A Trinh-Duc","year":"2021","unstructured":"Trinh-Duc A, Labeyrie M-A, Caillard A, Ben Hassen W, Mebazaa A, Chousterman BG (2021) Effects of levosimendan on occurrence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a case\u2013control study. Crit Care 25(1):396. https:\/\/doi.org\/10.1186\/s13054-021-03824-x","journal-title":"Crit Care"},{"key":"30_CR73","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.curtheres.2015.01.001","volume":"77","author":"M Kivikko","year":"2015","unstructured":"Kivikko M, Kuoppam\u00e4ki M, Soinne L, Sundberg S, Pohjanjousi P, Ellmen J, Roine RO (2015) Oral levosimendan increases cerebral blood flow velocities in patients with a history of stroke or transient ischemic attack: a pilot safety study. Curr Ther Res 77:46\u201351. https:\/\/doi.org\/10.1016\/j.curtheres.2015.01.001","journal-title":"Curr Ther Res"},{"key":"30_CR74","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejphar.2015.01.037","volume":"750","author":"J Levijoki","year":"2015","unstructured":"Levijoki J, Kivikko M, Pollesello P, Sallinen J, Hyttil\u00e4-Hopponen M, Kuoppam\u00e4ki M, Haasio K, Gr\u00f6hn O, Miettinen R, Puoliv\u00e4li J, T\u00e4htivaara L, Yrj\u00e4nheikki J, Haapalinna A (2015) Levosimendan alone and in combination with valsartan prevents stroke in Dahl salt-sensitive rats. Eur J Pharmacol 750:132\u2013140. https:\/\/doi.org\/10.1016\/j.ejphar.2015.01.037","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"30_CR75","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12872-018-0784-6","volume":"18","author":"U Ansari","year":"2018","unstructured":"Ansari U, El-Battrawy I, Fastner C, Behnes M, Sattler K, Huseynov A, Baumann S, T\u00fcl\u00fcmen E, Borggrefe M, Akin I (2018) Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy. BMC Cardiovasc Disord 18(1):54. https:\/\/doi.org\/10.1186\/s12872-018-0784-6","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"30_CR76","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1080\/14740338.2021.1951700","volume":"20","author":"Y-X Long","year":"2021","unstructured":"Long Y-X, Cui D-Y, Kuang X, Hu Y, Hu S, Wang C-P, Liu Z-Z (2021) Effect of levosimendan on renal function in background of left ventricular dysfunction: a meta-analysis of randomized trials. Expert Opin Drug Saf 20(11):1411\u20131420. https:\/\/doi.org\/10.1080\/14740338.2021.1951700","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"30_CR77","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/jcm10051032","volume":"10","author":"WC Chen","year":"2021","unstructured":"Chen WC, Lin MH, Chen CL, Chen YC, Chen CY, Lin YC, Hung CC (2021) Comprehensive comparisons among inotropic agents on mortality and risk of renal dysfunction in patients who underwent cardiac surgery: a network meta-analysis of randomized controlled trials. J Clin Med 10(5):1032. https:\/\/doi.org\/10.3390\/jcm10051032","journal-title":"J Clin Med"},{"issue":"18","key":"30_CR78","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.3390\/jcm10184120","volume":"10","author":"W-C Chen","year":"2021","unstructured":"Chen W-C, Lin M-H, Chen C-L, Lai Y-C, Chen C-Y, Lin Y-C, Hung C-C (2021) Comprehensive comparison of the effect of inotropes on cardiorenal syndrome in patients with advanced heart failure: a network meta-analysis of randomized controlled trials. J Clin Med 10(18):4120. https:\/\/doi.org\/10.3390\/jcm10184120","journal-title":"J Clin Med"},{"issue":"1","key":"30_CR79","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12871-019-0888-2","volume":"19","author":"JL Guerrero Orriach","year":"2019","unstructured":"Guerrero Orriach JL, Navarro Arce I, Hernandez Rodriguez P, Raig\u00f3n Ponferrada A, Malo Manso A, Ramirez Aliaga M, Ramirez Fernandez A, Escalona Belmonte JJ, Bellido Estevez I, Gomez Luque A, Barrera Serrano R, Toledo Medina CS, Rubio Navarro M, Cruz Ma\u00f1as J (2019) Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists. BMC Anesthesiol 19(1):212. https:\/\/doi.org\/10.1186\/s12871-019-0888-2","journal-title":"BMC Anesthesiol"},{"key":"30_CR80","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3389\/fphar.2020.01331","volume":"11","author":"JL Guerrero-Orriach","year":"2020","unstructured":"Guerrero-Orriach JL, Malo-Manso A, Ramirez-Aliaga M, Florez Vela AI, Gal\u00e1n-Ortega M, Moreno-Cortes I, Gonzalez-Almendros I, Ramirez-Fernandez A, Ariza-Villanueva D, Escalona-Belmonte JJ, Quesada-Mu\u00f1oz G, Sep\u00falveda-Haro E, Romero-Molina S, Bellido-Estevez I, Gomez-Luque A, Rubio-Navarro M, Alcaide-Torres J, Santiago-Fernandez C, Garrido-Sanchez L, Cruz-Ma\u00f1as J (2020) Renal and neurologic benefit of levosimendan vs dobutamine in patients with low cardiac output syndrome after cardiac surgery: clinical trial FIM-BGC-2014-01. Front Pharmacol 11:1331. https:\/\/doi.org\/10.3389\/fphar.2020.01331","journal-title":"Front Pharmacol"},{"issue":"1","key":"30_CR81","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13054-021-03628-z","volume":"25","author":"M Thol\u00e9n","year":"2021","unstructured":"Thol\u00e9n M, Ricksten S-E, Lannemyr L (2021) Effects of levosimendan on renal blood flow and glomerular filtration in patients with acute kidney injury after cardiac surgery: a double blind, randomized placebo-controlled study. Crit Care 25(1):207. https:\/\/doi.org\/10.1186\/s13054-021-03628-z","journal-title":"Crit Care"},{"issue":"16","key":"30_CR82","doi-asserted-by":"publisher","first-page":"e008455","DOI":"10.1161\/JAHA.117.008455","volume":"7","author":"L Lannemyr","year":"2018","unstructured":"Lannemyr L, Ricksten S, Rundqvist B, Andersson B, Bartfay S, Ljungman C, Dahlberg P, Bergh N, Hjalmarsson C, Gilljam T, Bollano E, Karason K (2018) Differential effects of levosimendan and dobutamine on glomerular filtration rate in patients with heart failure and renal impairment: a randomized double-blind controlled trial. J Am Heart Assoc 7(16):e008455. https:\/\/doi.org\/10.1161\/JAHA.117.008455","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"30_CR83","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3760\/cma.j.cn112137-20190712-01555","volume":"100","author":"YN Zhang","year":"2020","unstructured":"Zhang YN, Jia M, Pan Y, Lin JR, Cao JL, Lin Y, Qiu Q (2020) Influencing factors of postoperative acute kidney injury in patients undergoing cardiac surgery [Chinese]. Zhonghua Yi Xue Za Zhi 100(12):928\u2013932. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20190712-01555","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"30_CR84","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ahj.2020.10.066","volume":"231","author":"OK Jawitz","year":"2021","unstructured":"Jawitz OK, Stebbins AS, Raman V, Alhanti B, van Diepen S, Heringlake M, Fremes S, Whitlock R, Meyer SR, Mehta RH, Stafford-Smith M, Goodman SG, Alexander JH, Lopes RD (2021) Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: insights from the LEVO-CTS trial. Am Heart J 231:18\u201324. https:\/\/doi.org\/10.1016\/j.ahj.2020.10.066","journal-title":"Am Heart J"},{"issue":"3","key":"30_CR85","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ihj.2021.02.010","volume":"73","author":"B John","year":"2021","unstructured":"John B, Babu M, Shaji S, Abraham S, Abdullakutty J (2021) Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function. Indian Heart J 73(3):372\u2013375. https:\/\/doi.org\/10.1016\/j.ihj.2021.02.010","journal-title":"Indian Heart J"},{"issue":"1","key":"30_CR86","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13613-021-00810-y","volume":"11","author":"C-C Chan","year":"2021","unstructured":"Chan C-C, Lee K-T, Ho W-J, Chan Y-H, Chu P-H (2021) Levosimendan use in patients with acute heart failure and reduced ejection fraction with or without severe renal dysfunction in critical cardiac care units: a multi-institution database study. Ann Intens Care 11(1):27. https:\/\/doi.org\/10.1186\/s13613-021-00810-y","journal-title":"Ann Intens Care"},{"issue":"2","key":"30_CR87","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000504543","volume":"45","author":"N Guo","year":"2020","unstructured":"Guo N, Wang Z, Bow LM, Cui X, Zhang L, Xian W, Sun H, Tian J (2020) Cardiac inotropes offer protection of renal function in patients with kidney transplantation. Kidney Blood Press Res 45(2):331\u2013338. https:\/\/doi.org\/10.1159\/000504543","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"30_CR88","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s00134-017-4832-y","volume":"43","author":"M Joannidis","year":"2017","unstructured":"Joannidis M, Druml W, Forni LG, Groeneveld ABJ, Honore PM, Hoste E, Ostermann M, Oudemans-van Straaten HM, Schetz M (2017) Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the working group on prevention, AKI section, European Society of Intensive Care Medicine. Intens Care Med 43(6):730\u2013749. https:\/\/doi.org\/10.1007\/s00134-017-4832-y","journal-title":"Intens Care Med"},{"issue":"2","key":"30_CR89","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10741-018-9673-4","volume":"23","author":"P Di Nicol\u00f2","year":"2018","unstructured":"Di Nicol\u00f2 P (2018) The dark side of the kidney in cardio-renal syndrome: renal venous hypertension and congestive kidney failure. Heart Fail Rev 23(2):291\u2013302. https:\/\/doi.org\/10.1007\/s10741-018-9673-4","journal-title":"Heart Fail Rev"},{"issue":"5","key":"30_CR90","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jchf.2021.01.015","volume":"9","author":"D Burkhoff","year":"2021","unstructured":"Burkhoff D, Borlaug BA, Shah SJ, Zolty R, Tedford RJ, Thenappan T, Zamanian RT, Mazurek JA, Rich JD, Simon MA, Chung ES, Raza F, Majure DT, Lewis GD, Preston IR, Rich S (2021) Levosimendan improves hemodynamics and exercise tolerance in PH-HFpEF. J Am Coll Cardiol Heart Fail 9(5):360\u2013370. https:\/\/doi.org\/10.1016\/j.jchf.2021.01.015","journal-title":"J Am Coll Cardiol Heart Fail"},{"issue":"9","key":"30_CR91","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.cardfail.2021.05.022","volume":"27","author":"MI Brener","year":"2021","unstructured":"Brener MI, Hamid NB, Sunagawa K, Borlaug BA, Shah SJ, Rich S, Burkhoff D (2021) Changes in stressed blood volume with levosimendan in pulmonary hypertension from heart failure with preserved ejection fraction: insights regarding mechanism of action from the HELP trial. J Card Fail 27(9):1023\u20131026. https:\/\/doi.org\/10.1016\/j.cardfail.2021.05.022","journal-title":"J Card Fail"},{"issue":"6","key":"30_CR92","doi-asserted-by":"publisher","first-page":"585","DOI":"10.6515\/ACS.201911_35(6).20190327A","volume":"35","author":"YB Wang","year":"2019","unstructured":"Wang YB, Hao GZ, Jiang YF, Fu XH, Fan WZ, Miao Q, Wang Q, Li HX, Gu XS (2019) Effects of levosimendan on right ventricular function in patients with acute decompensated heart failure. Acta Cardiol Sin 35(6):585\u2013591. https:\/\/doi.org\/10.6515\/ACS.201911_35(6).20190327A","journal-title":"Acta Cardiol Sin"},{"issue":"27","key":"30_CR93","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"issue":"3","key":"30_CR94","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/eurjhf\/hfn045","volume":"11","author":"A Mebazaa","year":"2009","unstructured":"Mebazaa A, Nieminen MS, Filippatos GS, Cleland JG, Salon JE, Thakkar R, Padley RJ, Huang B, Cohen-Solal A (2009) Levosimendan vs. dobutamine: outcomes for acute heart failure patients on \u03b2-blockers in SURVIVE. Eur J Heart Fail 11(3):304\u2013311. https:\/\/doi.org\/10.1093\/eurjhf\/hfn045","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"30_CR95","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ehf2.13168","volume":"8","author":"M Tavares-Silva","year":"2021","unstructured":"Tavares-Silva M, Saraiva F, Pinto R, Amorim S, Silva JC, Leite-Moreira AF, Maciel MJ, Louren\u00e7o AP (2021) Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates. ESC Heart Fail 8(2):908\u2013917. https:\/\/doi.org\/10.1002\/ehf2.13168","journal-title":"ESC Heart Fail"},{"key":"30_CR96","doi-asserted-by":"publisher","unstructured":"Hansen MS, Andersen A, Nielsen-Kudsk JE (2018) Levosimendan in pulmonary hypertension and right heart failure. Pulm Circ. https:\/\/doi.org\/10.1177\/2045894018790905","DOI":"10.1177\/2045894018790905"},{"issue":"1","key":"30_CR97","doi-asserted-by":"publisher","first-page":"1801906","DOI":"10.1183\/13993003.01906-2018","volume":"53","author":"MM Hoeper","year":"2019","unstructured":"Hoeper MM, Benza RL, Corris P, de Perrot M, Fadel E, Keogh AM, K\u00fchn C, Savale L, Klepetko W (2019) Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J 53(1):1801906. https:\/\/doi.org\/10.1183\/13993003.01906-2018","journal-title":"Eur Respir J"},{"issue":"2","key":"30_CR98","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0828-282X(09)70477-5","volume":"25","author":"JG Howlett","year":"2009","unstructured":"Howlett JG, McKelvie RS, Arnold JMO, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H, Heckman GA, Herd AM, Isaac D, Jong P, Kouz S, Liu P, Mann E, Moe GW, Tsuyuki RT, Ross HJ, White M (2009) Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 25(2):85\u2013105. https:\/\/doi.org\/10.1016\/S0828-282X(09)70477-5","journal-title":"Can J Cardiol"},{"issue":"20","key":"30_CR99","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","volume":"137","author":"MA Konstam","year":"2018","unstructured":"Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, Kociol RD, Lewis EF, Mehra MR, Pagani FD, Raval AN, Ward C (2018) Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association. Circulation 137(20):e578\u2013e622. https:\/\/doi.org\/10.1161\/CIR.0000000000000560","journal-title":"Circulation"},{"issue":"1","key":"30_CR100","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13054-019-2674-4","volume":"23","author":"B Cholley","year":"2019","unstructured":"Cholley B, Levy B, Fellahi J-L, Longrois D, Amour J, Ouattara A, Mebazaa A (2019) Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper. Crit Care 23(1):385. https:\/\/doi.org\/10.1186\/s13054-019-2674-4","journal-title":"Crit Care"},{"issue":"11","key":"30_CR101","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/jcm8111834","volume":"8","author":"P Pollesello","year":"2019","unstructured":"Pollesello P, Ben Gal T, Bettex D, Cerny V, Comin-Colet J, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Harjola V-P, Herpain A, Heringlake M, Heunks L, Husebye T, Ivancan V, Karason K, Kaul S, Kubica J, Mebazaa A, M\u00f8lgaard H, Parissis J, Parkhomenko A, P\u00f5der P, P\u00f6lzl G, Vrtovec B, Yilmaz MB, Papp Z (2019) Short-term therapies for treatment of acute and advanced heart failure\u2014why so few drugs available in clinical use, why even fewer in the pipeline? J Clin Med 8(11):1834. https:\/\/doi.org\/10.3390\/jcm8111834","journal-title":"J Clin Med"},{"issue":"6","key":"30_CR102","doi-asserted-by":"publisher","first-page":"714","DOI":"10.23736\/S0375-9393.20.14866-1","volume":"87","author":"A Carsetti","year":"2021","unstructured":"Carsetti A, Bignami E, Cortegiani A, Donadello K, Donati A, Foti G, Grasselli G, Romagnoli S, Antonelli M, De Blasio E, Forfori F, Guarracino F, Scolletta S, Tritapepe L, Scudeller L, Cecconi M, Girardis M (2021) Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-art and expert consensus. Minerva Anestesiol 87(6):714\u2013732. https:\/\/doi.org\/10.23736\/S0375-9393.20.14866-1","journal-title":"Minerva Anestesiol"},{"issue":"5","key":"30_CR103","doi-asserted-by":"publisher","first-page":"798","DOI":"10.5603\/CJ.a2021.0078","volume":"28","author":"F Sanfilippo","year":"2021","unstructured":"Sanfilippo F, La Via L, Merola F, Astuto M (2021) Mortality reduction with levosimendan in patients with heart failure: current evidence is underpowered. Cardiol J 28(5):798\u2013799. https:\/\/doi.org\/10.5603\/CJ.a2021.0078","journal-title":"Cardiol J"},{"issue":"11","key":"30_CR104","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jchf.2020.08.012","volume":"8","author":"AR Garan","year":"2020","unstructured":"Garan AR, Kanwar M, Thayer KL, Whitehead E, Zweck E, Hernandez-Montfort J, Mahr C, Haywood JL, Harwani NM, Wencker D, Sinha SS, Vorovich E, Abraham J, O\u2019Neill W, Burkhoff D, Kapur NK (2020) Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality. J Am Coll Cardiol Heart Fail 8(11):903\u2013913. https:\/\/doi.org\/10.1016\/j.jchf.2020.08.012","journal-title":"J Am Coll Cardiol Heart Fail"},{"issue":"5","key":"30_CR105","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/bja\/aeu446","volume":"114","author":"T Greco","year":"2015","unstructured":"Greco T, Calabr\u00f2 MG, Covello RD, Greco M, Pasin L, Morelli A, Landoni G, Zangrillo A (2015) A Bayesian network meta-analysis on the effect of inodilatory agents on mortality. Br J Anaesth 114(5):746\u2013756. https:\/\/doi.org\/10.1093\/bja\/aeu446","journal-title":"Br J Anaesth"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-021-00030-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-021-00030-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-021-00030-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T11:03:11Z","timestamp":1643022191000},"score":1,"resource":{"primary":{"URL":"https:\/\/janesthanalgcritcare.biomedcentral.com\/articles\/10.1186\/s44158-021-00030-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1186\/s44158-021-00030-7","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SR is an employee of Tenax Therapeutics which has the license to develop levosimendan in North America. PP is an employee of Orion Pharma, where levosimendan was discovered and developed as a treatment for AHF. In the last 5 years, MG, DB, HVG, FG, JLG-O, MH, AH, LMAH, HVG, DK-M, PM, GM, S-ER, AR, WT, ST, and ZZ have received honoraria for lectures and scientific advice and\/or grants for investigator-initiated studies by Orion Pharma. MB, CD, SF, JG, VP, and MS do not declare any relevant conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}